Free Trial

IBEX (NASDAQ:IBEX) Stock: Insider Julie Casteel Sells 11,677 Shares

IBEX logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • IBEX insider Julie Casteel sold 11,677 shares at an average price of $50.72, totaling about $592,257. She retained 100,594 shares after the sale.
  • IBEX shares rose 3.9% to $52.23 on Tuesday, while the company’s latest quarterly results beat estimates: EPS was $1.10 versus $0.90 expected, and revenue was $175.23 million versus $169.31 million expected.
  • Analysts’ consensus rating remained Hold, with an average price target of $44.50.
  • Interested in IBEX? Here are five stocks we like better.

IBEX Limited (NASDAQ:IBEX - Get Free Report) insider Julie Casteel sold 11,677 shares of the business's stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $50.72, for a total transaction of $592,257.44. Following the transaction, the insider owned 100,594 shares in the company, valued at approximately $5,102,127.68. This trade represents a 10.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

IBEX Stock Up 3.9%

NASDAQ IBEX traded up $1.95 during trading hours on Tuesday, hitting $52.23. 432,801 shares of the stock were exchanged, compared to its average volume of 124,838. The company has a market cap of $696.75 million, a price-to-earnings ratio of 15.83 and a beta of 0.74. IBEX Limited has a 12-month low of $25.94 and a 12-month high of $52.29. The stock has a 50-day moving average of $43.25 and a 200 day moving average of $34.57.

IBEX (NASDAQ:IBEX - Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The company reported $1.10 earnings per share for the quarter, beating analysts' consensus estimates of $0.90 by $0.20. IBEX had a return on equity of 28.96% and a net margin of 7.19%. The company had revenue of $175.23 million for the quarter, compared to analyst estimates of $169.31 million.

Institutional Trading of IBEX

A number of institutional investors have recently added to or reduced their stakes in IBEX. Dimensional Fund Advisors LP grew its position in IBEX by 7.5% during the first quarter. Dimensional Fund Advisors LP now owns 358,191 shares of the company's stock worth $9,607,000 after buying an additional 24,942 shares during the period. Tieton Capital Management LLC purchased a new position in IBEX in the second quarter valued at about $8,353,000. Hillsdale Investment Management Inc. increased its holdings in IBEX by 2.8% in the first quarter. Hillsdale Investment Management Inc. now owns 264,200 shares of the company's stock valued at $7,086,000 after buying an additional 7,300 shares in the last quarter. Pinnacle Associates Ltd. lifted its position in shares of IBEX by 3.4% during the 3rd quarter. Pinnacle Associates Ltd. now owns 208,027 shares of the company's stock valued at $8,999,000 after acquiring an additional 6,932 shares during the period. Finally, Globeflex Capital L P acquired a new stake in shares of IBEX during the 2nd quarter valued at approximately $3,112,000. Hedge funds and other institutional investors own 81.24% of the company's stock.

Analyst Ratings Changes

A number of research firms recently weighed in on IBEX. Weiss Ratings upgraded IBEX from a "buy (b-)" rating to a "buy (b)" rating in a research note on Monday, October 12th. Wall Street Zen raised IBEX from a "buy" rating to a "strong-buy" rating in a report on Saturday. Robert W. Baird increased their price objective on IBEX from $40.00 to $44.00 and gave the stock a "neutral" rating in a research report on Monday, September 28th. Finally, Royal Bank Of Canada increased their price objective on IBEX from $40.00 to $45.00 and gave the stock a "sector perform" rating in a research report on Tuesday. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $44.50.

Read Our Latest Research Report on IBEX

About IBEX

(Get Free Report)

IBEX Limited NASDAQ: IBEX is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services. The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.

Further Reading

Insider Buying and Selling by Quarter for IBEX (NASDAQ:IBEX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in IBEX Right Now?

Before you consider IBEX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IBEX wasn't on the list.

While IBEX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines